Meningitis B Vaccination Uptake Low Among Eligible Youths, Sparking Outbreak Concerns

Health watchdogs are concerned about a potential resurgence of meningitis B as a significant number of eligible young people have not yet received the vaccine. A one-off vaccination program was initiated this year following outbreaks that began in Kent in March and resulted in two fatalities.

The UK Health Security Agency (UKHSA) has warned that similar outbreaks could occur again and is appealing to young people to get the meningitis B vaccine. The jab is being offered through pharmacies to Year 13 pupils, aged 17 and 18, and individuals under 25 starting university this autumn.

As of September 20, only 26.6 percent of Year 13 pupils had taken advantage of the vaccination offer. This means that 212,549 out of 799,840 eligible students have been vaccinated. While health officials note that coverage is gradually increasing, they express concern over the number of individuals who remain unprotected.

University students are identified as being at a higher risk due to social mixing patterns. Research indicates that first-year university students are approximately seven times more likely to contract meningitis than their peers who do not attend university. The UKHSA advises eligible individuals to receive two doses of the vaccine, administered 28 days apart, as soon as possible. Appointments can be booked via the NHS website.

Dr. Sharif Ismail, UKHSA consultant epidemiologist, highlighted the devastating impact of meningitis B, noting that survivors can face lifelong health consequences. He further stated that recent genomic studies reveal the sudden and unpredictable emergence of dangerous new strains of meningitis B, similar to the one observed in the Kent outbreak, underscoring the possibility of future outbreaks.

The vaccination program commenced on July 20 and is scheduled to continue until March 31, 2027. Data indicates that the vaccine is highly effective, providing robust protection for at least five years.

Caroline Temmink, NHS England's director of vaccination, urged eligible individuals, particularly new university students, to get vaccinated promptly. The menB vaccination is available at high street pharmacies nationwide.

Juliette Kenny, 18, died on March 14, just one day after exhibiting symptoms of the illness. Her family has been advocating for routine access to the meningitis B (menB) vaccine for teenagers and young people. The outbreak in Kent was the most rapid and extensive recorded in the UK, and other smaller clusters of meningitis among young people have exceeded expectations.

Close proximity and prolonged contact in settings like university halls of residence, shared housing, and social gatherings can elevate the risk of contracting menB. Cases typically peak between October and November.